Overview
Synoptis Industrial provides pharmaceutical supply-chain services, including import, packaging, quality control, batch certification, clinical-trial logistics, and warehousing and consignment. It stores APIs and pharmaceutical raw materials under GMP conditions and operates to GMP and GDP standards, drawing on more than 30 years of industry experience.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2013-07-15. Active
06 1090 1506 0000 0001 5507 9014- 22 1090 1506 0000 0001 5507 9114
- 57 1090 1506 0000 0001 5507 9066
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 329.0KPLN 328,988 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
The making of declarations on behalf of the company requires the joint action of two members of the management board, or of one member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 39,999 | $540,235.01 | 12.2696% | |
Others | 286,001 | $3,862,790.38 | 87.7304% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Sciencepharmasp. z o.o. | $111,783,976.52 | sciencepharma.com | ||
| Delpharm PoznańS.A. | $110,900,246.81 | delpharm.com | ||
| ICN Polfa RzeszówS.A. | $85,044,250.03 | icnpolfa.pl | ||
| Synoptis Pharmasp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| US Pharmaciasp. z o.o. | $41,267,631.19 | uspharmacia.pl | ||
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A. | $40,633,950.51 | biomed.pl | ||
| Przedsiębiorstwo Farmaceutyczne Farmapolsp. z o.o. | $21,462,728.43 | farmapol.pl | ||
| Synektik Pharmasp. z o.o. | $13,215,198.91 | synektik.com.pl | ||
| Cefea sp. z o.o.sp. k. | $9,898,555.57 | cefea.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-03-27 | Name change (Synoptis Industrial Spółka Z Ograniczoną Odpowiedzialnośicą → Synoptis Industrial) | |
| 2020-12-09 | Address change (Szosa Bydgoska 58, 87-100, Toruń → Ul. Forteczna 35-37, 87-100, Toruń) | |
| 2017-08-11 | Share capital change (12,300,000.00 PLN → 16,300,000.00 PLN) | |
| 2016-06-23 | Share capital change (9,000,000.00 PLN → 12,300,000.00 PLN) | |
| 2015-08-20 | Share capital change (7,000,000.00 PLN → 9,000,000.00 PLN) |
FAQ
Last updated: 2026-10-02